Ardelyx, Inc. (NASDAQ:ARDX) has a beta value of 1.83 and has seen 1,225,832 shares traded in the recent trading session. The company, currently valued at $541.98 Million, closed the recent trade at $6.01 per share which meant it lost -$0.23 on the day or -3.84% during that session. The ARDX stock price is -46.59% off its 52-week high price of $8.81 and 30.78% above the 52-week low of $4.16. If we look at the company’s 10-day average daily trading volume, we find that it stood at 453.6 Million shares traded. The 3-month trading volume is 607.47 Million shares.
The consensus among analysts is that Ardelyx, Inc. (ARDX) is a Buy stock at the moment, with a recommendation rating of 1.3. None of the analysts rate the stock as a Sell, while none rate it as Overweight. None out of 6 have rated it as a Hold, with 6 advising it as a Buy. None have rated the stock as Underweight. The expected earnings per share for the stock is -$0.28.
Ardelyx, Inc. (NASDAQ:ARDX) trade information
Despite being -3.84% in the red today, the stock has traded in the green over the last five days, with the highest price hit on Monday, Sep 14 when the ARDX stock price touched $6.26-3 or saw a rise of 3.67%. Year-to-date, Ardelyx, Inc. shares have moved -19.65%, while the 5-day performance has seen it change 2.2%. Over the past 30 days, the shares of Ardelyx, Inc. (NASDAQ:ARDX) have changed 7.49%. Short interest in the company has seen 6.34 Million shares shorted with days to cover at 0.01.
Wall Street analysts have a consensus price target for the stock at $13, which means that the shares’ value could jump 116.31% from current levels. The projected low price target is $11 while the price target rests at a high of $15. In that case, then, we find that the current price level is +149.58% off the targeted high while a plunge would see the stock lose 83.03% from current levels.
Ardelyx, Inc. (ARDX) estimates and forecasts
Figures show that Ardelyx, Inc. shares have underperformed across the wider relevant industry. The company’s shares have gained +43.56% over the past 6 months, with this year growth rate of -23.81%, compared to 16.1% for the industry. Other than that, the company has, however, increased its growth outlook for the 2020 fiscal year revenue. Growth estimates for the current quarter are 24.3% and -7.4% for the next quarter. Revenue growth from the last financial year stood is estimated to be +1.1%.
5 analysts offering their estimates for the company have set an average revenue estimate of $850Million for the current quarter. 5 have an estimated revenue figure of $1.45 Million for the next quarter concluding in December 01, 2020. Year-ago sales stood $3.01 Million and $2.25 Million respectively for this quarter and the next, and analysts expect sales will grow by -71.8% for the current quarter and -35.6% for the next.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -53.5% over the past 5 years. Earnings growth for 2020 is a modest +9.3% while over the next 5 years, the company’s earnings are expected to increase by 30%.
Ardelyx, Inc. (NASDAQ:ARDX)’s Major holders
Insiders own 0.65% of the company shares, while shares held by institutions stand at 85.95% with a share float percentage of 86.52%. Investors are also buoyed by the number of investors in a company, with Ardelyx, Inc. having a total of 143 institutions that hold shares in the company. The top two institutional holders are NEA Management Company, LLC with over 13.63 Million shares worth more than $94.34 Million. As of June 29, 2020, NEA Management Company, LLC held 15.29% of shares outstanding.
The other major institutional holder is RA Capital Management, L.P., with the holding of over 6.26 Million shares as of June 29, 2020. The firm’s total holdings are worth over $43.33 Million and represent 7.02% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Vanguard Total Stock Market Index Fund and SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF. As of June 29, 2020, the former fund manager holds about 2.14% shares in the company for having 1908992 shares of worth $13.21 Million while later fund manager owns 1.64 Million shares of worth $11.34 Million as of June 29, 2020, which makes it owner of about 1.84% of company’s outstanding stock.